Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 6Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 8OTHER 4

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Dermatologic 4Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Keratosis, Actinic 4Neoplasms 2Keratosis 2Stomach Neoplasms 1Precancerous Conditions 1Lymphoma 1Leukemia, Myeloid, Acute 1Carcinoma 1Breast Neoplasms 1Bone-Metastatic, Castration-Resistant Prostate Cancer 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
INDUSTRY × tirbanibulin × Clear all
NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT05260073 2024-09-20

PROAK

Almirall, S.A.

Completed
300 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT01074138 2023-02-02

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Athenex, Inc.

Phase 2 Completed
31 enrolled
Genitourinary

Bone-Metastatic, Castration-Resistant Prostate Cancer

NCT01397799 2015-12-07

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Athenex, Inc.

Phase 1 Completed
24 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01764087 2015-05-18

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

Hanmi Pharmaceutical Company Limited

Phase 1/2 Unknown
60 enrolled
BreastGastrointestinal

Breast Neoplasms, Carcinoma, Neoplasms, Stomach Neoplasms

NCT00658970 2011-06-08

Evaluation of KX2-391 in Patients With Advanced Malignancies

Athenex, Inc.

Phase 1 Completed
50 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡